Related Experiment Video
Updated: Dec 25, 2025
Humanized Mediator Release Assay as a Read-Out for Allergen Potency
Published on: June 29, 2021
Tripterine: A Potential Anti-Allergic Compound
Bao-Jun Zhu1, Ze-Quan Qian1, Hui-Run Yang1
1Department of Pediatrics, Putuo Hospital of Traditional Chinese Medicine, East of Second Floor Ward, 19 Wenkang Street, Putuo District, Zhoushan, Zhejiang 316100, China.
Background:
Tripterine (TRI), an active monomer in Tripterygium wilfordii, has significant pharmacological activities, such as anti-inflammatory, immunosuppressive and anti-tumor activities. TRI may be used to treat allergic diseases because of its characteristics of immunosuppression.
Objective:
This study aims to explore the anti-allergic effect of TRI.
Methods:
It was tested in vivo and in vitro in this study.
Results:
The results showed that TRI could significantly inhibit histamine release from rat peritoneal mast cells; the inhibitory effect of TRI on histamine release was stronger than that of other known histamine inhibitors such as disodium cromoglyceride. TRI also significantly inhibited systemic anaphylactic shock induced by compound 48/80 and skin allergy induced by IgE, and inhibited the expression of inflammatory factors secreted by Human Mast Cells (HMC-1) induced by Phorbol 12-Myristate 13- Acetate (PMA) and calcium carrier A23187. In the animal model of allergic rhinitis induced by Ovalbumin (OA), the scores of friction, histamine, IgE, inflammatory factors and inflammatory cells decreased after TRI was administered orally or nasally.
Conclusion:
TRI, as an active immunoregulatory factor, has great potential in the treatment of mast cell-mediated allergic diseases.
More Related Videos
10:20Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b
Published on: November 11, 2016
06:34A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma
Published on: June 4, 2017
Related Concept Videos
01:15Upper Respiratory Drugs: First and Second-Generation Antihistamines
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
01:27Allergic Drug Reactions
02:06Allergic Reactions
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...